
Omada Health Announces Launch of Initial Public Offering
SAN FRANCISCO--(BUSINESS WIRE)--Omada Health, the virtual between-visit healthcare provider, announced today that it has launched the roadshow for its proposed initial public offering of its common stock. Omada Health has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (the 'SEC') to offer an aggregate of 7,900,000 shares of its common stock. In addition, Omada Health intends to grant the underwriters a 30-day option to purchase up to an additional 1,185,000 shares of common stock at the initial public offering price, less underwriting discounts and commissions. The initial public offering price is expected to be between $18.00 and $20.00 per share. Omada Health has applied to list its common stock on the Nasdaq Global Market under the ticker symbol 'OMDA.'
Morgan Stanley, Goldman Sachs & Co. LLC, and J.P. Morgan are acting as lead book-running managers for the proposed offering. Barclays and Evercore ISI are acting as joint book-running managers for the proposed offering. Canaccord Genuity and Needham & Company are acting as co-managers for the proposed offering.
The proposed offering will be made only by means of a prospectus. Copies of the preliminary prospectus may be obtained from: Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, New York 10014, or by email at prospectus@morganstanley.com; Goldman Sachs & Co. LLC, Attention: Prospectus Department, 200 West Street, New York, New York 10282, by telephone at (866) 471-2526, by facsimile at (212) 902-9316, or by email at prospectus-ny@ny.email.gs.com; or J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, or by email at prospectus-eq_fi@jpmorgan.com and postsalemanualrequests@broadridge.com.
A registration statement relating to these securities has been filed with the SEC but has not yet become effective. These securities may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
Omada Health
Omada Health is a virtual-first healthcare provider that nurtures lifelong health, one day at a time. Omada care teams implement clinically-validated behavior change protocols for individuals living with diabetes, hypertension, prediabetes, and musculoskeletal issues. With more than a decade of experience and data, and 29 peer-reviewed publications that showcase its clinical and economic results, Omada is designed to help improve health outcomes and contain healthcare costs. Omada's scope exceeds 2,000 customers, including health plans, health systems, and employers ranging in size from small businesses to Fortune 500s.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Wire
2 hours ago
- Business Wire
Circus SE Moves Global Headquarters to Munich
MUNICH--(BUSINESS WIRE)--Circus SE (XETRA: CA1), a global technology company in AI software and autonomous robotics for the food service industry, today announces the relocation of its global headquarters to Munich, marking a strategic move to strengthen its position in one of Europe's most dynamic technology hubs. With a strong foundation already laid in the region through years of mechanical engineering and robotics development, the company is doubling down on Munich as its core location for AI innovation, advanced robotics, and pre-series production of its new CA-M military-grade autonomous robot platform. 'As OpenAI, NVIDIA and other global leaders invest in Munich and the global demand for intelligent automation surges, Munich has become one of the few places in the world where cutting-edge research meets world-class engineering talent,' said Nikolas Bullwinkel, CEO and Founder of Circus. 'We're building the future of robotics here – from our civilian food service automation to next-gen defense solutions – and Munich will be our long-term launchpad.' The new HQ will serve as a central R&D hub, attracting top talent and enabling closer collaboration with leading universities, research centers, and the region's industrial base. 'The ecosystem in Munich is continuously evolving into a global hotspot for robotics and AI,' says Dr. Arne Rost, member of the Circus Advisory Board Member and Managing Director of the Venture Lab Robotics/AI from the Technical University Munich. 'The city brings together academic excellence, entrepreneurial drive, and international deep-tech talent – and Circus is one of the most ambitious companies actively shaping this ecosystem.' Circus' expansion signals a broader trend of global tech players choosing Munich as their base to scale high-impact innovation. With serial production underway and global deployments of its robotics system CA-1 lined up, Circus is set to redefine how intelligent machines integrate into everyday life — and Munich is where that future begins. About Circus SE Circus SE (XETRA: CA1) is a global technology company in the field of embodied AI and AI software for the food service industry, driving innovation and autonomy in labor-intensive sectors. With its core product, the CA-1 robot, Circus is a pioneer in applying embodied AI, integrating cutting-edge technologies into real-world operations, and transforming the food service industry. By combining advanced robotics, AI-driven software, and a mission to solve global challenges, Circus is shaping the future of autonomous systems and redefining human-AI collaboration. Headquartered in Germany and with a rapidly growing international presence, Circus leads the next generation of AI applications.


Business Insider
4 hours ago
- Business Insider
Regeneron price target lowered to $650 from $700 at Citi
Citi analyst Geoff Meacham lowered the firm's price target on Regeneron (REGN) to $650 from $700 and keeps a Buy rating on the shares. The company reported mixed itepekimab Phase 3 COPD results in former smokers, the analyst tells investors in a research note. The firm says that wWhile Aerify-1 met its primary endpoint in both dosing arms, Aerify-2 failed to achieve statistical significance improvement at week 52. While Aerify-1 was positive, the path to approval is unclear, contends Citi. Confident Investing Starts Here:
Yahoo
7 hours ago
- Yahoo
Tocexa Crypto Exchange Limited Secures SEC and MSB Licenses, Advancing Global Compliance Strategy
New federal licenses position Tocexa as a secure, AI-driven platform bridging traditional finance and digital assets for global investors Image by Tocexa Crypto Exchange Limited Denver, Colorado, June 01, 2025 (GLOBE NEWSWIRE) -- Tocexa Crypto Exchange Limited announced today that it has officially completed registration with the U.S. Securities and Exchange Commission (SEC) and has secured its Money Services Business (MSB) license from the Financial Crimes Enforcement Network (FinCEN), a bureau within the U.S. Department of the by Tocexa Crypto Exchange Limited Tocexa's SEC registration (CIK: 0002066357, File No: 021-544925) became effective on May 1, 2025, authorizing the platform to conduct regulated activities involving U.S. stocks, ETFs, tokenized securities, and compliant digital assets. Simultaneously, Tocexa obtained its MSB license (Registration Number: 31000297125437) with approval signed on April 9, 2025, empowering the company to offer fiat-to-crypto exchange, remittance, and money transmission services in all U.S. states and territories. These dual federal credentials solidify Tocexa's role as a compliant and secure infrastructure provider for the tokenized finance ecosystem. The platform's licensing enables seamless integration with the traditional financial system, paving the way for institutional partnerships, regulated digital securities onboarding, and fiat gateway deployment. 'This milestone is more than a regulatory checkbox—it's a statement of our long-term commitment to global trust and transparency,' said Felix Wegner, CEO of Tocexa. 'We're proud to build an AI-powered trading infrastructure anchored in real compliance.' Looking forward, Tocexa has announced plans to expand its licensing footprint in key international jurisdictions, including: Hong Kong SFC license application (Type 1 & 7 underway), UK FCA registration for cryptoasset activities, Dubai VARA licensing for Web3, tokenized securities, and institutional onboarding. These developments reinforce Tocexa's mission to build a truly borderless, compliant, and intelligent digital trading environment for global investors. About Tocexa Crypto Exchange Limited Tocexa Crypto Exchange Limited is a U.S.-registered digital asset and securities trading platform headquartered in Denver, Colorado. The company is licensed by the U.S. SEC and FinCEN, enabling it to offer legal crypto exchange, tokenized stock trading, and institutional cross-border financial services. Powered by its proprietary AI trading system ChainIQ™, Tocexa is building the next generation of secure, compliant, and intelligent global trading infrastructure. Media Contact:Isabella HartTocexa Crypto Exchange Limitedinfo@ Attachment Image by Tocexa Crypto Exchange Limited